News

Global Health EDCTP3 has received 38 applications for the EDCTP Prizes 2027, following the 24 September deadline, with submissions received across all seven prize categories.

Global Health EDCTP3 has received 243 applications by the 2 September deadline for the 2026 single-stage call. Applicants have requested nearly €491.7 million in Global Health EDCTP3 funding. The indicative available budget at call closure is €36.6 million.

Registrations are now open for participation in the EDCTP Forum 2027.

Global Health EDCTP3 is investing over €10 million in rapid tests, digital solutions and new approaches to overcome persistent barriers to tuberculosis control.

Global Health EDCTP3 invests €39 million to advance novel antimalarial compounds, a repurposed antiviral, and a triple therapy for severe malaria. Co-funding from Pharmaceutical companies, product development partnerships and research institutions brings the total investment to more than €76 million

In-Kind contributions to Additional Activities (IKAAs) are health research and capacity development projects that EDCTP Association member countries directly fund and manage with their own national funding and align with Global Health EDCTP3 goals.

Researchers and institutions from African Lusophone countries are making an increasingly important contribution to Global Health EDCTP3, already taking part in 25% of the project portfolio, a substantial increase compared to previous EDCTP Programme iterations.

From a child-friendly deworming pill to a simpler treatment for a deadly brain infection, EDCTP-funded trials have changed WHO recommendations. Now Global Health EDCTP3 is putting that experience into practice by joining the Global Clinical Trials Forum (GCTF).

This feature is the second in a series highlighting EDCTP-supported experts driving progress across global health. It showcases another ten influential figures whose work has been enabled through EDCTP fellowships, research projects and capacity-strengthening initiatives.